SPRING HARBOR HOSPITAL
1. Target Overview & Investment Thesis
SPRING HARBOR HOSPITAL is a 96-bed safety-net/medicaid heavy in CUMBERLAND, ME with $77.6M in net patient revenue and a -56.0% operating margin. The hospital serves a payer mix of 10.1% Medicare, 57.0% Medicaid, and 32.9% commercial.
Thesis: Turnaround. Our ML models identify $5.7M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -56.0% to -48.6% (+736bps).
| Net Revenue HCRIS | $77.6M |
| Current EBITDA COMPUTED | $-43.4M |
| Operating Margin COMPUTED | -56.0% |
| Occupancy HCRIS | 66.6% |
| Revenue / Bed COMPUTED | $808K |
| Net-to-Gross HCRIS | 62.7% |
| Distress Probability ML | 60.8% |
2. Market Context & Competitive Position
ME has 38 Medicare-certified hospitals with a median operating margin of -8.3%. The target's margin of -56.0% places it below the state median. Among 14 size-comparable peers (48-192 beds), the median margin is -11.4%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (48-192), prioritizing same-state peers. 14 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| SPRING HARBOR HOSPITAL (Target) | ME | 96 | $77.6M | -56.0% |
| MAINEGENERAL MEDICAL CENTER | ME | 186 | $559.8M | -17.8% |
| CENTRAL MAINE MEDICAL CENTER | ME | 187 | $396.9M | -25.7% |
| SOUTHERN MAINE HEALTH CARE | ME | 140 | $352.3M | -9.9% |
| MERCY HOSPITAL | ME | 77 | $240.0M | -11.6% |
| MID COAST HOSPITAL | ME | 93 | $213.6M | -14.0% |
| YORK HOSPITAL | ME | 54 | $197.1M | -3.6% |
| ST. MARYS REGIONAL MEDICAL CEN | ME | 140 | $196.3M | -32.8% |
| ST JOSEPH HOSPITAL | ME | 99 | $176.8M | -9.2% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $5.7M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $1.6M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $1.6M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $1.5M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $944K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $50K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-43.4M |
| + RCM Uplift | +$5.7M |
| Pro Forma EBITDA | $-37.7M |
| Current Margin | -56.0% |
| Pro Forma Margin | -48.6% |
| WC Released (1x) | $3.0M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-66.8M | $-229.3M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-66.8M | $-273.9M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-60.1M | $-276.8M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-60.1M | $-319.7M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-73.5M | $-236.2M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-73.5M | $-283.6M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Medium | Elevated Medicaid exposure (57.0%) | Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims |
| High | Elevated distress probability | Model estimates 60.8% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 14 hospitals with 48-192 beds
- Same-state prioritization (n=15)
- Comp margins: P25=-18.8% / P50=-11.4% / P75=-7.8%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.